Scarica l'app Stockscreener
226.94
1.72%
3.6164
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABBV Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$223.32
Aprire:
$224.235
Volume 24 ore:
2.94M
Relative Volume:
0.51
Capitalizzazione di mercato:
$400.98B
Reddito:
$59.64B
Utile/perdita netta:
$2.36B
Rapporto P/E:
171.23
EPS:
1.3253
Flusso di cassa netto:
$19.68B
1 W Prestazione:
+1.81%
1M Prestazione:
-2.24%
6M Prestazione:
+18.88%
1 anno Prestazione:
+31.03%
Intervallo 1D:
$223.56
$228.30
Intervallo di 1 settimana:
$220.23
$228.30
Portata 52W:
$164.39
$244.81
Abbvie Inc Stock (ABBV) Company Profile
Nome
Abbvie Inc
Settore
Industria
Telefono
(847) 932-7900
Indirizzo
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Confronta ABBV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
226.88 | 394.69B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
LLY
Lilly Eli Co
|
1,059.38 | 919.64B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
214.37 | 509.76B | 92.15B | 25.12B | 20.46B | 10.36 |
|
NVS
Novartis Ag Adr
|
134.44 | 254.37B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
99.90 | 248.95B | 63.90B | 19.05B | 13.05B | 7.5596 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-10 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-11-04 | Downgrade | DZ Bank | Buy → Hold |
| 2025-10-14 | Downgrade | Erste Group | Buy → Hold |
| 2025-10-01 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-09-17 | Aggiornamento | Berenberg | Hold → Buy |
| 2025-08-12 | Ripresa | Piper Sandler | Overweight |
| 2025-08-07 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-12-10 | Ripresa | BofA Securities | Neutral |
| 2024-12-05 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | Iniziato | Wolfe Research | Outperform |
| 2024-11-04 | Aggiornamento | Argus | Hold → Buy |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-06-05 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-05-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-01-29 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | Downgrade | HSBC Securities | Buy → Hold |
| 2023-12-11 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-10-30 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Ripresa | UBS | Neutral |
| 2023-09-29 | Iniziato | Raymond James | Outperform |
| 2023-07-25 | Iniziato | William Blair | Mkt Perform |
| 2023-07-14 | Iniziato | HSBC Securities | Buy |
| 2023-04-05 | Downgrade | Argus | Buy → Hold |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2023-02-22 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | Aggiornamento | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | Iniziato | Credit Suisse | Outperform |
| 2022-11-08 | Downgrade | Societe Generale | Buy → Hold |
| 2022-08-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | Iniziato | SVB Leerink | Underperform |
| 2022-05-06 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2022-02-28 | Downgrade | UBS | Buy → Neutral |
| 2022-02-03 | Reiterato | BMO Capital Markets | Outperform |
| 2022-02-03 | Reiterato | Barclays | Equal Weight |
| 2022-02-03 | Reiterato | BofA Securities | Neutral |
| 2022-02-03 | Reiterato | Goldman | Neutral |
| 2022-01-13 | Iniziato | Redburn | Buy |
| 2022-01-12 | Reiterato | BMO Capital Markets | Outperform |
| 2021-12-09 | Ripresa | Wells Fargo | Overweight |
| 2021-11-23 | Aggiornamento | Societe Generale | Hold → Buy |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2020-11-10 | Ripresa | Bernstein | Outperform |
| 2020-09-29 | Iniziato | Berenberg | Hold |
| 2020-06-23 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Aggiornamento | Argus | Hold → Buy |
| 2020-05-18 | Ripresa | BofA/Merrill | Neutral |
| 2020-05-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-05-11 | Ripresa | Morgan Stanley | Overweight |
| 2020-04-20 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | Downgrade | Societe Generale | Buy → Hold |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-02-06 | Iniziato | Mizuho | Buy |
| 2020-01-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | Reiterato | Cowen | Outperform |
| 2019-09-26 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-08-20 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | Iniziato | Goldman | Neutral |
| 2019-04-29 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
Mostra tutto
Abbvie Inc Borsa (ABBV) Ultime notizie
AbbVie’s (ABBV) Options Flow Implies That the Smart Money Could Be Up to Something - Barchart.com
AbbVie's Upside Potential Limited in Pipeline-Light 2026, BofA Securities Says - marketscreener.com
AbbVie’s Growth Story Faces A Pipeline Pause - Finimize
Valeo Financial Advisors LLC Sells 29,989 Shares of AbbVie Inc. $ABBV - MarketBeat
Texas Permanent School Fund Corp Sells 46,907 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Hold Rating: Balancing Growth Opportunities with Valuation and Pipeline Challenges - TipRanks
Orion Porfolio Solutions LLC Purchases 16,520 Shares of AbbVie Inc. $ABBV - MarketBeat
Stonebridge Wealth Management LLC Purchases New Stake in AbbVie Inc. $ABBV - MarketBeat
Thrivent Financial for Lutherans Purchases 125,719 Shares of AbbVie Inc. $ABBV - MarketBeat
Marex Group plc Acquires Shares of 5,914 AbbVie Inc. $ABBV - MarketBeat
Rep. Julie Johnson Sells Off Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Geneos Wealth Management Inc. - MarketBeat
American Trust Has $4.43 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Ranked #15 in the Inaugural Fortune 100 Best Companies to Work For Southeast Asia 2025 List - PR Newswire
AbbVie (ABBV) Stock: What to Know Before the US Market Opens on December 15, 2025 - ts2.tech
MASTERINVEST Kapitalanlage GmbH Makes New $12.37 Million Investment in AbbVie Inc. $ABBV - MarketBeat
AbbVie’s Phase III CLL Study: A Potential Game-Changer in Cancer Treatment - TipRanks
Kentucky Retirement Systems Sells 7,443 Shares of AbbVie Inc. $ABBV - MarketBeat
North Dallas Bank & Trust Co. Invests $1.68 Million in AbbVie Inc. $ABBV - MarketBeat
Public Sector Pension Investment Board Has $165.77 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever. - The Motley Fool
Advisory Services Network LLC Grows Position in AbbVie Inc. $ABBV - MarketBeat
Assessing AbbVie (ABBV) Valuation After HSBC Upgrade, Strong Earnings, and Dividend Hike - Yahoo Finance UK
My Top 3 Healthcare Stocks to Buy in 2026 - Finviz
AbbVie Inc. $ABBV Shares Acquired by Curi Capital LLC - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Engineers Gate Manager LP - MarketBeat
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 59,257 Shares of AbbVie Inc. $ABBV - MarketBeat
Bridgeway Capital Management LLC Purchases Shares of 110,140 AbbVie Inc. $ABBV - MarketBeat
Bellevue Group AG Boosts Stock Position in AbbVie Inc. $ABBV - MarketBeat
Benjamin Edwards Inc. Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Ameriprise Financial Inc. Sells 3,127,890 Shares of AbbVie Inc. $ABBV - MarketBeat
Adage Capital Partners GP L.L.C. Lowers Position in AbbVie Inc. $ABBV - MarketBeat
Is AbbVie stock too cheap to ignore at today's price? - MSN
AbbVie Stock (ABBV) After-Hours Update: What Happened on Dec. 12, 2025—and What to Watch Before the Next Market Open - ts2.tech
ABBV Stock News: Lenz Therapeutics Faces Setback with FDA Report - GuruFocus
Morgan Stanley Maintains Overweight Rating on ABBV, Raises Price Target to $269 | ABBV Stock News - GuruFocus
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 - Finviz
Morgan Stanley Adjusts Price Target on AbbVie to $269 From $261, Maintains Overweight Rating - marketscreener.com
AbbVie Slipped Below 50-Day SMA Last Week: How to Play the Stock - Finviz
Treasurer of the State of North Carolina Sells 27,645 Shares of AbbVie Inc. $ABBV - MarketBeat
HSBC upgrades AbbVie (ABBV) to buy, raises price target to $265 - MSN
AbbVie Inc. $ABBV Shares Bought by Quantinno Capital Management LP - MarketBeat
Hamilton Capital LLC Cuts Holdings in AbbVie Inc. $ABBV - MarketBeat
Peapack Gladstone Financial Corp Acquires 20,164 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Nebula Research & Development LLC - MarketBeat
Canada Pension Plan Investment Board Has $466.58 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Diversify Advisory Services LLC Purchases 10,883 Shares of AbbVie Inc. $ABBV - MarketBeat
Bayesian Capital Management LP Sells 4,700 Shares of AbbVie Inc. $ABBV - MarketBeat
Alliancebernstein L.P. Increases Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025) - ts2.tech
Hot Picks: Large-cap health care stocks to watch for dividend growth - BNN Bloomberg
Abbvie Inc Azioni (ABBV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.23%
0.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):